Thomas Jefferson University

Results of the GEMSTONE-301 study showed that sugemalimab was well tolerated and effective in patients with stage III non-small cell lung cancer. It was the top story in hematology/oncology last week.

Andrew E. Aplin, PhD, has been appointed deputy director for scientific strategy at Sidney Kimmel Cancer Center — Jefferson Health.

Use of mepivacaine for spinal anesthesia during total hip arthroplasty led to earlier ambulation and a greater percentage of same-day discharge compared with hyperbaric and isobaric bupivacaine, according to results.

Treatment with biologic injections may lead to serious complications, such as infections requiring multiple surgical procedures and inflammatory reactions, according to published results.

Research suggests that the number of cancer survivors in the United States will exceed 26 million by the middle of the century, according to Ana Maria Lopez, MD, MPH, MACP.

Few African American individuals with cancer completed advance directives despite a high level of advance care planning readiness in this population, according to results presented at the virtual Oncology Nursing Society Congress.

American Cancer Society has named Karen Knudsen, MBA, PhD, as its first female CEO, the organization announced in a press release.

A risk prediction model for lung cancer calculated scores that did not align with diagnoses in African American patients, according to results of a cross-sectional study.

Association of Community Cancer Centers announced the newly elected members of its executive committee and board of trustees for the 2021-2022 term.

Patients who met evidence-based medicine guidelines for elective lumbar fusion had a greater than three times improvement in outcomes compared with patients who did not meet evidence-based medicine guideline criteria, according to results.